The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A salvage treatment with combination of docetaxel and epirubicin in patients with recurrent or metastatic gastric cancer after fluoropyrimidine failure.
Jun Ho Yi
No relevant relationships to disclose
Su Jin Heo
No relevant relationships to disclose
Choong-kun Lee
No relevant relationships to disclose
Minkyu Jung
No relevant relationships to disclose
Hyo Song Kim
No relevant relationships to disclose
Hyun Cheol Chung
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose